Else Nutrn (BABYF) Stock Price, News & Analysis

Company Overview

Else Nutrition Holdings Inc is a plant-based infant and toddler nutrition company that develops dairy-free, soy-free and gluten-free formula powders under its flagship ELSE brand. The company’s core product line includes Stage 1 infant formula and Stage 3 toddler nutrition powders formulated with a proprietary blend of almond, buckwheat and tapioca ingredients designed to mimic the nutritional profile of traditional milk‐based formulas. These products are non-GMO and aim to address food sensitivities and allergen concerns in early childhood nutrition.

Founded in 2019 and headquartered in Tel Aviv, Israel, Else Nutrition began commercial sales in 2021 with initial distribution in Canada and Israel. Its manufacturing takes place in European Union-certified facilities, and products are sold through e-commerce channels as well as selected retail partners. Beyond Canada and Israel, Else Nutrition has entered into distribution partnerships in parts of Europe and is working toward regulatory approvals to support an expansion into the U.S. market.

Led by CEO Hadar Barshewitz-Attias and a management team with backgrounds in nutrition science and consumer packaged goods, Else Nutrition places a strong emphasis on research and development. The company is investing in clinical studies and regulatory compliance to support the safety and efficacy of its existing products, while also exploring the development of additional age-stage formulas and new delivery formats within the plant-based pediatric nutrition category.

Key Stats

• Today's Range: $0.02 to $0.03
• 50-Day Range: $0.01 to $0.06
• 52-Week Range: $0.01 to $0.08
• Volume: 1.32 million shs
• Average Volume: 456,867 shs
• Market Capitalization: $6.77 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BABYF Stock Analysis - Frequently Asked Questions

How have BABYF shares performed this year?

Else Nutrn's stock was trading at $0.0119 at the beginning of the year. Since then, BABYF stock has increased by 89.1% and is now trading at $0.0225.

How were Else Nutrn's earnings last quarter?

Else Nutrn Hldg (OTCMKTS:BABYF) announced its earnings results on Thursday, September, 11th. The company reported ($0.03) EPS for the quarter. The business had revenue of $1.08 million for the quarter. Else Nutrn had a negative trailing twelve-month return on equity of 565.09% and a negative net margin of 180.47%.

How do I buy shares of Else Nutrn?

Shares of BABYF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 9/11/2025
• Today: 9/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:BABYF
• CIK: N/A
• Web: www.elsenutrition.com
• Phone: 888-879-3573
• Fax: N/A
• Employees: 32
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$11.08 million
• Net Margins: -180.47%
• Pretax Margin: -164.68%
• Return on Equity: -565.09%
• Return on Assets: -151.63%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.86
• Quick Ratio: 0.23

Sales & Book Value

• Annual Sales: $5.82 million
• Price / Sales: 1.80
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: 2.80

Miscellaneous

• Outstanding Shares: 374,110,000
• Free Float: N/A
• Market Cap: $10.48 million
• Optionable: Not Optionable
• Beta: 1.31